{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:41:29Z","timestamp":1767847289915,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T00:00:00Z","timestamp":1521072000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12913-018-2985-1","type":"journal-article","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T09:41:29Z","timestamp":1521106889000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["An examination of user costs in relation to smokers using a cessation service based in the UK"],"prefix":"10.1186","volume":"18","author":[{"given":"Neil","family":"Walker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9529-1685","authenticated-orcid":false,"given":"Yaling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasiliki","family":"Kiparoglou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhash","family":"Pokhrel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayley","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"van Woerden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,15]]},"reference":[{"issue":"1","key":"2985_CR1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1056\/NEJMra1308383","volume":"370","author":"P Jha","year":"2014","unstructured":"Jha P, Peto R. Global effects of smoking, of quitting, and of taxing tobacco. N Engl J Med. 2014;370(1):60\u20138.","journal-title":"N Engl J Med"},{"issue":"22","key":"2985_CR2","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1002\/cncr.28326","volume":"119","author":"PF Pinsky","year":"2013","unstructured":"Pinsky PF, Church TR, Izmirlian G, Kramer BS. The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology. Cancer. 2013;119(22):3976\u201383.","journal-title":"Cancer"},{"issue":"2","key":"2985_CR3","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/MCP.0b013e328341ce98","volume":"17","author":"D Menzies","year":"2011","unstructured":"Menzies D. The case for a worldwide ban on smoking in public places. Curr Opin Pulm Med. 2011;17(2):116\u201322.","journal-title":"Curr Opin Pulm Med"},{"issue":"49","key":"2985_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta14490","volume":"14","author":"T Coleman","year":"2010","unstructured":"Coleman T, Agboola S, Leonardi-Bee J, Taylor M, McEwen A, McNeill A. Relapse prevention in UK stop smoking services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis. Health Technol Assess. 2010;14(49):1\u2013152. iii-iv","journal-title":"Health Technol Assess"},{"key":"2985_CR5","unstructured":"National Centre for Smoking Cessation and Training [ http:\/\/www.ncsct.co.uk\/index.php ]. Accessed 18 Sept 2016."},{"key":"2985_CR6","unstructured":"Stop smoking services [ https:\/\/www.nice.org.uk\/guidance\/ph10 ]. Accessed 18 Sept 2016."},{"issue":"8","key":"2985_CR7","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1111\/add.12172","volume":"108","author":"H Pin\u00e9-Abata","year":"2013","unstructured":"Pin\u00e9-Abata H, McNeill A, Murray R, Bitton A, Rigotti N, Raw M. A survey of tobacco dependence treatment services in 121 countries. Addiction. 2013;108(8):1476\u201384.","journal-title":"Addiction"},{"issue":"7437","key":"2985_CR8","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1136\/bmj.328.7437.454","volume":"328","author":"A Molyneux","year":"2004","unstructured":"Molyneux A. Nicotine replacement therapy. BMJ. 2004;328(7437):454\u20136.","journal-title":"BMJ"},{"issue":"suppl 4","key":"2985_CR9","first-page":"32","volume":"59","author":"EC Settle","year":"1998","unstructured":"Settle EC. Bupropion sustained release: side effect profile. J Clin Psychiatry. 1998;59(suppl 4):32\u20136.","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"2985_CR10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10557-010-6246-8","volume":"24","author":"JJ McNeil","year":"2010","unstructured":"McNeil JJ, Piccenna L, Ioannides-Demos LL. Smoking cessation-recent advances. Cardiovasc Drugs Ther. 2010;24(4):359\u201367.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"6","key":"2985_CR11","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3109\/07853890.2012.705016","volume":"44","author":"EJ Mills","year":"2012","unstructured":"Mills EJ, Wu P, Lockhart I, Thorlund K, Puhan M, Ebbert JO. Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: a systematic review and multiple treatment meta-analysis. Ann Med. 2012;44(6):588\u201397.","journal-title":"Ann Med"},{"issue":"33","key":"2985_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta18330","volume":"18","author":"J Leaviss","year":"2014","unstructured":"Leaviss J, Sullivan W, Ren S, Everson-Hock E, Stevenson M, Stevens JW, Strong M, Cantrell A. What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation. Health Technol Assess. 2014;18(33):1\u2013120.","journal-title":"Health Technol Assess"},{"key":"2985_CR13","first-page":"CD009329","volume":"5","author":"K Cahill","year":"2013","unstructured":"Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013;5:CD009329.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"2985_CR14","doi-asserted-by":"publisher","first-page":"174","DOI":"10.7326\/0003-4819-154-3-201102010-00007","volume":"154","author":"DK Owens","year":"2011","unstructured":"Owens DK, Qaseem A, Chou R, Shekelle P. High-value, cost-conscious health care: concepts for clinicians to evaluate the benefits, harms, and costs of medical interventions. Ann Intern Med. 2011;154(3):174\u201380.","journal-title":"Ann Intern Med"},{"issue":"8","key":"2985_CR15","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.clinthera.2012.07.002","volume":"34","author":"K Athanasakis","year":"2012","unstructured":"Athanasakis K, Igoumenidis M, Karampli E, Vitsou E, Sykara G, Kyriopoulos J. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece. Clin Ther. 2012;34(8):1803\u201314.","journal-title":"Clin Ther"},{"issue":"1","key":"2985_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3810\/hp.2012.02.946","volume":"40","author":"MA Lutz","year":"2012","unstructured":"Lutz MA, Lovato P, Cuesta G. Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua. Hosp Pract (Minneap). 2012;40(1):35\u201343.","journal-title":"Hosp Pract (Minneap)"},{"issue":"2","key":"2985_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1742-1241.2011.02877.x","volume":"66","author":"M Mahmoudi","year":"2012","unstructured":"Mahmoudi M, Coleman C, Sobieraj D. Systematic review of the cost-effectiveness of varenicline vs. bupropion for smoking cessation. Int J Clin Pract. 2012;66(2):171\u201382.","journal-title":"Int J Clin Pract"},{"issue":"3","key":"2985_CR18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1136\/tc.2005.011551","volume":"15","author":"J Cornuz","year":"2006","unstructured":"Cornuz J, Gilbert A, Pinget C, McDonald P, Slama K, Salto E, Paccaud F. Cost-effectiveness of pharmacotherapies for nicotine dependence in primary care settings: a multinational comparison. Tob Control. 2006;15(3):152\u20139.","journal-title":"Tob Control"},{"issue":"3","key":"2985_CR19","doi-asserted-by":"publisher","first-page":"206","DOI":"10.7326\/0003-4819-151-3-200908040-00126","volume":"151","author":"BR Luce","year":"2009","unstructured":"Luce BR, Kramer JM, Goodman SN, Connor JT, Tunis S, Whicher D, Schwartz JS. Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change. Ann Intern Med. 2009;151(3):206\u20139.","journal-title":"Ann Intern Med"},{"issue":"5","key":"2985_CR20","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2165\/00019053-199915050-00001","volume":"15","author":"DA Revicki","year":"1999","unstructured":"Revicki DA, Frank L. Pharmacoeconomic evaluation in the real world. PharmacoEconomics. 1999;15(5):423\u201334.","journal-title":"PharmacoEconomics"},{"issue":"12","key":"2985_CR21","doi-asserted-by":"publisher","first-page":"e1000194","DOI":"10.1371\/journal.pmed.1000194","volume":"6","author":"T-P van Staa","year":"2009","unstructured":"van Staa T-P, Leufkens HG, Zhang B, Smeeth L. A comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective cox-2 inhibitors as an example. PLoS Med. 2009;6(12):e1000194.","journal-title":"PLoS Med"},{"key":"2985_CR22","doi-asserted-by":"crossref","unstructured":"Coyle K, Coyle D, Lester-George A, West R, Nemeth B, Hiligsmann M, Trapero-Bertran M, Leidl R, Pokhrel S. Development and application of an economic model (EQUIPTMOD) to assess the impact of smoking cessation. Addiction. 2017;","DOI":"10.1111\/add.14001"},{"issue":"4","key":"2985_CR23","first-page":"373","volume":"79","author":"World Medical Association Declaration of Helsinki","year":"2001","unstructured":"World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Organ. 2001;79(4):373\u20134.","journal-title":"Bull World Health Organ"},{"issue":"9","key":"2985_CR24","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","volume":"86","author":"TF Heatherton","year":"1991","unstructured":"Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict. 1991;86(9):1119\u201327.","journal-title":"Br J Addict"},{"key":"2985_CR25","unstructured":"UK Government. English indices of deprivation 2015. https:\/\/www.gov.uk\/government\/statistics\/english-indices-of-deprivation-2015 . Accessed 29 Dec 2016."},{"key":"2985_CR26","volume-title":"GenStat release 11 reference manual, part 2 directives","author":"R Payne","year":"2008","unstructured":"Payne R, Harding S, Murray D, Soutar D, Baird D, Glaser A, Channing I, Welham S, Gilmour A, Thompson R. GenStat release 11 reference manual, part 2 directives. Hemel Hempstead, UK: VSN International; 2008."},{"issue":"11","key":"2985_CR27","doi-asserted-by":"publisher","first-page":"e006945","DOI":"10.1136\/bmjopen-2014-006945","volume":"4","author":"S Pokhrel","year":"2014","unstructured":"Pokhrel S, Evers S, Leidl R, Trapero-Bertran M, Kalo Z, De Vries H, Crossfield A, Andrews F, Rutter A, Coyle K. EQUIPT: protocol of a comparative effectiveness research study evaluating cross-context transferability of economic evidence on tobacco control. BMJ Open. 2014;4(11):e006945.","journal-title":"BMJ Open"},{"issue":"1","key":"2985_CR28","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1186\/s12889-016-3672-y","volume":"16","author":"N Walker","year":"2016","unstructured":"Walker N, Van Woerden HC, Kiparoglou V, Yang Y, Robinson H, Croghan E. Gender difference and effect of pharmacotherapy: findings from a smoking cessation service. BMC Public Health. 2016;16(1):1038.","journal-title":"BMC Public Health"},{"key":"2985_CR29","doi-asserted-by":"crossref","unstructured":"Graham AL, Chang Y, Fang Y, Cobb NK, Tinkelman DS, Niaura RS, Abrams DB, Mandelblatt JS: Cost-effectiveness of internet and telephone treatment for smoking cessation: an economic evaluation of The iQUITT Study. Tobacco control 2012:tobaccocontrol-2012-050465.","DOI":"10.1136\/tobaccocontrol-2012-050465"},{"issue":"1","key":"2985_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/pubmed\/fdp074","volume":"32","author":"L Bauld","year":"2010","unstructured":"Bauld L, Bell K, McCullough L, Richardson L, Greaves L. The effectiveness of NHS smoking cessation services: a systematic review. J Public Health (Oxf). 2010;32(1):71\u201382.","journal-title":"J Public Health (Oxf)"},{"issue":"9","key":"2985_CR31","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.2105\/AJPH.82.9.1238","volume":"82","author":"PL Pirie","year":"1992","unstructured":"Pirie PL, McBride CM, Hellerstedt W, Jeffery RW, Hatsukami D, Allen S, Lando H. Smoking cessation in women concerned about weight. Am J Public Health. 1992;82(9):1238\u201343.","journal-title":"Am J Public Health"},{"issue":"6","key":"2985_CR32","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/eurpub\/ckp075","volume":"19","author":"K Bolin","year":"2009","unstructured":"Bolin K, Wilson K, Benhaddi H, De Nigris E, Marbaix S, Mork A-C, Aubin H-J. Cost-effectiveness of varenicline compared with nicotine patches for smoking cessation\u2014results from four European countries. The European Journal of Public Health. 2009;19(6):650\u20134.","journal-title":"The European Journal of Public Health"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-018-2985-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12913-018-2985-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-018-2985-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T19:10:40Z","timestamp":1570907440000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-018-2985-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,15]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2985"],"URL":"https:\/\/doi.org\/10.1186\/s12913-018-2985-1","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,15]]},"assertion":[{"value":"31 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Users of the Quit-51 service are informed at initial registration that data recorded in relation to their cessation attempt may be used for research purposes. Consent was provided by Quit-51 for this data to be used in analysis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SP is associate editor of BMC Health Service Research. HR works for Quit-51 who provided the data which were analysed in this work. Apart from this, the authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"182"}}